SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-014454
Filing Date
2021-11-04
Accepted
2021-11-04 07:46:03
Documents
101
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20210930x10q.htm   iXBRL 10-Q 2421892
2 EX-10.2 tmb-20210930xex10d2.htm EX-10.2 504580
3 EX-31.1 tmb-20210930xex31d1.htm EX-31.1 10563
4 EX-31.2 tmb-20210930xex31d2.htm EX-31.2 10617
5 EX-32.1 tmb-20210930xex32d1.htm EX-32.1 7922
  Complete submission text file 0001558370-21-014454.txt   10900280

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20210930.xsd EX-101.SCH 92536
7 EX-101.CAL tmb-20210930_cal.xml EX-101.CAL 56421
8 EX-101.DEF tmb-20210930_def.xml EX-101.DEF 457981
9 EX-101.LAB tmb-20210930_lab.xml EX-101.LAB 552528
10 EX-101.PRE tmb-20210930_pre.xml EX-101.PRE 631824
11 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20210930x10q_htm.xml XML 1636861
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39801 | Film No.: 211378053
SIC: 2834 Pharmaceutical Preparations